Featured Interview: President Tom Donaldson of Signet International Holdings, Inc. (OTC: SIGN)

President Tom Donaldson of Signet International Holdings, Inc. , talks new patented InCharge energy source, hopes for monetizing, and other technology patents.

Read more

Featured Interview: CEO Ernest Letiziano of Signet International Holdings, Inc. (OTC: SIGN)

CEO Ernest Letiziano of Signet International Holdings, Inc., talks about his background,
The ConnREAP™ device, and new patented InCharge energy source.

Read more

Todos and Amarantus Announce Completion of LymPro PET 1 Study by Leipzig University for Alzheimer’s Blood Diagnostic LymPro Test 2.0

REHOVOT, Israel and NEW YORK, April 08, 2019 (GLOBE NEWSWIRE) — Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics

Read more

Featured Interview: CEO Matt Goldman of Image Protect, Inc. (OTCPink: IMTL)

CEO Matt Goldman of Image Protect, Inc., discusses how the Image Protect business got started, growing into the world’s largest digital image monetization platform, and moving into the advertising business.

Read more

WORKSPORT EXPANDS PORTFOLIO WITH U.S. PATENT GRANTED FOR HARD-FOLDING TONNEAU COVERS

Award is second FNHI patent, two reaching approval stage, five more to be applied for Three trademarks also sought Toronto, Ontario,

Read more

IntelGenx Facility Undergoes U.S. FDA Pre-Approval Inspection Related to RIZAPORT® NDA

SAINT LAURENT, Quebec, Jan. 30, 2019 (GLOBE NEWSWIRE) — IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company,

Read more

IntelGenx Provides Update on Phase 2a Montelukast VersaFilm™ Clinical Trial

Eight Alzheimer’s Disease Patients Randomized to Date with Two Additional Sites Expected SAINT LAURENT, Quebec, Jan. 23, 2019 (GLOBE NEWSWIRE)

Read more

Featured Interview: President Bernard Rubin of DNA Brands, Inc. (OTCPink: DNAX)

President Bernard Rubin of DNA Brands, Inc., talks about details of recent acquisition, the synergy of various holdings, and growing their energy drink brands.

Read more

Featured Interview: CEO Alex Wasyl of Nexien BioPharma, Inc. (OTCQB: NXEN)

CEO Alex Wasyl of Nexien BioPharma, Inc., discusses recent acquisition, consolidation, and being engaged in the formulation, development, and commercialization of cannabinoid based drugs.

Read more

Featured Interview: CEO John Poss of GB Sciences, Inc. (OTCQB: GBLX)

CEO John Poss of GB Sciences, Inc., gives details on possible acquisitions, revenue growth, and scientific research.

Read more